There's no single FDA-approved dosing protocol dosing is based on smaller studies, nutrient requirements, and clinical experience across compounding pharmacies
Although rare, some reports have indicated that GLP-1 agonists, including semaglutide, could increase the risk of macular edema in people with diabetes
Determining the true burden of kidney stone disease
What is PlushCares approach to compounded medications during shortages
The findings here highlight that to maintain weight loss, people should continue on tirzepatide long-term, says Fatima Cody Stanford, MD, MPH, an associate professor of medicine at Harvard Medical School and obesity medicine specialist at Massachusetts General Hospital, both in Boston
Short half-life GLP-1 drugs can have short half-lives, which may limit their efficacy even with frequent dosing